Company intelligence / Profile preview

Recursion Foundation

Salt Lake City, Utah, United States

Ownership: Private
Employees: ~800
Development stage: Other

Overview

Recursion Pharmaceuticals is a clinical-stage biotech company using AI to industrialize drug discovery, with multiple clinical programs in oncology, rare genetic diseases, and infectious disease. Its lead programs are in Phase 2 and Phase 2/3 trials, and it has advanced capabilities in automation, data science, and supercomputing to rapidly generate and test drug candidates[1][3][6].

Therapeutic areas: Infectious DiseasesGastroenterologyNeurologyOncology
Modalities: Small molecule
Industry: Biotech

Partnerships

BayerRoche/GenentechTakeda PharmaceuticalUniversity of Utah Research FoundationOhio State Innovation Foundation

Beyond the preview

Go deeper on Recursion Foundation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recursion Foundation.

Explore the full profile